Health Equity
Sen. Durbin Highlights Success of HEAL Program
RUSH supports community-focused anti-violence efforts
Ear, Nose & Throat
Ten Specialists at RUSH Named ‘Beauty Gurus’
Chicago magazine recognizes specialists in facial plastic surgery, oculoplastics and plastic surgery
Pregnancy & Childbirth
Nurse Home Visits Help Moms and Newborns
Family Connects program aims to improve infant, maternal health
Healthy Aging & Caregiving
Models of Care for Caregivers
RUSH is paving the way for health systems across the country to help improve the health of caregivers and patients
COVID-19
'Long COVID' Not a Single Condition
New study data suggests 'long COVID” involves four distinct conditions
Research
Transforming Recovery Through Innovative Research
Gift supports physical medicine and rehabilitation research, honors Joseph Dragonette
University
RUSH Med Students Teach Livesaving Skills
RUSH group trains public in CPR, Narcan use and more
Patient Stories
Sam’s Story: Getting an Athlete Back on Track
After successful surgery, Sam learned a valuable lesson
Awards, Rankings and Recognitions
Nurse Receives DAISY Award for Providing Extraordinary Care
RUSH Copley honors Tanya Antal with inaugural DAISY award
Cancer
Genetic Profiling of Non-Small Cell Lung Cancer at RUSH with Mary Jo Fidler, MD
Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.
